JP2024539922A5 - - Google Patents
Info
- Publication number
- JP2024539922A5 JP2024539922A5 JP2024523981A JP2024523981A JP2024539922A5 JP 2024539922 A5 JP2024539922 A5 JP 2024539922A5 JP 2024523981 A JP2024523981 A JP 2024523981A JP 2024523981 A JP2024523981 A JP 2024523981A JP 2024539922 A5 JP2024539922 A5 JP 2024539922A5
- Authority
- JP
- Japan
- Prior art keywords
- alternatively
- alkyl
- pharmaceutically acceptable
- stereoisomer
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111269381.X | 2021-10-29 | ||
| CN202111269381 | 2021-10-29 | ||
| CN202210233624.2 | 2022-03-10 | ||
| CN202210233624 | 2022-03-10 | ||
| CN202210849103.X | 2022-07-19 | ||
| CN202210849103 | 2022-07-19 | ||
| CN202211274771.0 | 2022-10-18 | ||
| CN202211274771 | 2022-10-18 | ||
| PCT/CN2022/128251 WO2023072248A1 (zh) | 2021-10-29 | 2022-10-28 | 含吡啶基的化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539922A JP2024539922A (ja) | 2024-10-31 |
| JP2024539922A5 true JP2024539922A5 (https=) | 2025-10-28 |
Family
ID=86159245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523981A Pending JP2024539922A (ja) | 2021-10-29 | 2022-10-28 | ピリジル含有化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250002472A1 (https=) |
| EP (1) | EP4424676A4 (https=) |
| JP (1) | JP2024539922A (https=) |
| KR (1) | KR20240090588A (https=) |
| CN (1) | CN118055924A (https=) |
| AU (1) | AU2022376773A1 (https=) |
| CA (1) | CA3235436A1 (https=) |
| IL (1) | IL312179A (https=) |
| MX (1) | MX2024004871A (https=) |
| TW (1) | TW202321220A (https=) |
| WO (1) | WO2023072248A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121039118A (zh) * | 2023-04-28 | 2025-11-28 | 正大天晴药业集团股份有限公司 | 含三唑基的化合物 |
| WO2026082075A1 (zh) * | 2024-10-15 | 2026-04-23 | 杭州百诚医药科技股份有限公司 | 丙烯酰胺类化合物及其医药用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME03421B (me) * | 2013-06-21 | 2020-01-20 | Karyopharm Therapeutics Inc | 1,2,4-triazoli kao modulatori nuklearnog transporta i njihova upotreba |
| US10526295B2 (en) * | 2015-12-31 | 2020-01-07 | Karyopharm Therapeutics Inc. | Nuclear transport modulators and uses thereof |
| WO2019232724A1 (en) * | 2018-06-06 | 2019-12-12 | Xw Laboratories, Inc. | Compounds as nuclear transport modulators and uses thereof |
| CN110592141B (zh) * | 2018-06-13 | 2023-07-07 | 中国科学院上海有机化学研究所 | 用于调控基因编辑效率的化合物及其应用 |
| WO2020092965A1 (en) * | 2018-11-01 | 2020-05-07 | Karyopharm Therapeutics Inc. | E2f1 as a biomarker for treatments using xpo1 inhibitors |
| WO2021252900A1 (en) * | 2020-06-11 | 2021-12-16 | Karyopharm Therapeutics Inc. | Biomarkers for response to exportin-1 inhibitors in multiple myeloma patients |
| CN112538069A (zh) * | 2020-11-05 | 2021-03-23 | 苏州艾和医药科技有限公司 | 一种氮唑类衍生物或其药物可接受盐及其制备方法和用途 |
| CN113045550A (zh) * | 2021-03-12 | 2021-06-29 | 深圳济康医药科技有限公司 | 一种三氮唑类衍生物及其制备方法和应用 |
| CN113248474A (zh) * | 2021-05-24 | 2021-08-13 | 王能能 | 五元氮唑杂环衍生物及其制备方法和用途 |
-
2022
- 2022-10-28 CA CA3235436A patent/CA3235436A1/en active Pending
- 2022-10-28 WO PCT/CN2022/128251 patent/WO2023072248A1/zh not_active Ceased
- 2022-10-28 AU AU2022376773A patent/AU2022376773A1/en active Pending
- 2022-10-28 KR KR1020247016666A patent/KR20240090588A/ko active Pending
- 2022-10-28 IL IL312179A patent/IL312179A/en unknown
- 2022-10-28 EP EP22886123.3A patent/EP4424676A4/en active Pending
- 2022-10-28 US US18/703,482 patent/US20250002472A1/en active Pending
- 2022-10-28 JP JP2024523981A patent/JP2024539922A/ja active Pending
- 2022-10-28 CN CN202280066733.8A patent/CN118055924A/zh active Pending
- 2022-10-28 MX MX2024004871A patent/MX2024004871A/es unknown
- 2022-10-28 TW TW111141120A patent/TW202321220A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022535093A5 (https=) | ||
| JP2018524298A5 (https=) | ||
| RU2005107314A (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью | |
| JP2024539922A5 (https=) | ||
| JP2014511891A5 (https=) | ||
| JP2010523522A5 (https=) | ||
| JP2019521988A5 (https=) | ||
| RU2019141734A (ru) | Терапевтические соединения и композиции и способы их применения | |
| RU2003134544A (ru) | Амиды антраниловой кислоты, способы их получения, их применение в качестве антиаритмических средств, а также содержащие их фармацевтические композиции | |
| JP2013010792A5 (https=) | ||
| JP2006182786A5 (https=) | ||
| JP2019505529A5 (https=) | ||
| HUP0003386A2 (hu) | CRF antagonisták alkalmazása depresszió, kardiovaszkuláris betegségek kezelésére szolgáló gyógyszerkészítmények előállítására | |
| JP2014528464A5 (https=) | ||
| JP2009536620A5 (https=) | ||
| JP2006524222A5 (https=) | ||
| JP2009507896A5 (https=) | ||
| JP2017531619A5 (https=) | ||
| JP2005511547A5 (https=) | ||
| JP2017525699A5 (https=) | ||
| JP2007507494A5 (https=) | ||
| RU2009123525A (ru) | ПРОИЗВОДНЫЕ 5-СУЛЬФАНИЛМЕТИЛ[1,2,4}ТРИАЗОЛ[1,5-а]ПИРИМИДИН-7-ОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ CXCR2 | |
| JP2019535723A5 (https=) | ||
| JP2015172098A5 (https=) | ||
| RU2018102449A (ru) | Производные пиразоло[1,5-a]триазин-4-амина, применимые в терапии |